{
  "id": "score2_diabetes",
  "title": "Systematic Coronary Risk Evaluation 2-Diabetes (SCORE2-Diabetes)",
  "description": "Predicts 10-year cardiovascular disease (fatal and non-fatal myocardial infarction and stroke) risk in patients with type 2 diabetes aged under 70 years without prior cardiovascular disease.",
  "category": "cardiology",
  "version": "2023",
  "parameters": [
    {
      "name": "sex",
      "type": "string",
      "required": true,
      "description": "Biological sex",
      "options": ["male", "female"]
    },
    {
      "name": "age",
      "type": "integer",
      "required": true,
      "description": "Age in years",
      "validation": {
        "min": 40,
        "max": 69
      },
      "unit": "years"
    },
    {
      "name": "smoking",
      "type": "string",
      "required": true,
      "description": "Current smoking status",
      "options": ["current", "other"]
    },
    {
      "name": "systolic_bp",
      "type": "integer",
      "required": true,
      "description": "Systolic blood pressure",
      "validation": {
        "min": 80,
        "max": 250
      },
      "unit": "mmHg"
    },
    {
      "name": "total_cholesterol",
      "type": "float",
      "required": true,
      "description": "Total cholesterol",
      "validation": {
        "min": 2.0,
        "max": 12.0
      },
      "unit": "mmol/L"
    },
    {
      "name": "hdl_cholesterol",
      "type": "float",
      "required": true,
      "description": "HDL cholesterol",
      "validation": {
        "min": 0.5,
        "max": 3.5
      },
      "unit": "mmol/L"
    },
    {
      "name": "age_diabetes_diagnosis",
      "type": "integer",
      "required": true,
      "description": "Age at type 2 diabetes diagnosis",
      "validation": {
        "min": 18,
        "max": 69
      },
      "unit": "years"
    },
    {
      "name": "hba1c",
      "type": "float",
      "required": true,
      "description": "Glycated hemoglobin (HbA1c)",
      "validation": {
        "min": 20,
        "max": 130
      },
      "unit": "mmol/mol"
    },
    {
      "name": "egfr",
      "type": "float",
      "required": true,
      "description": "Estimated glomerular filtration rate (eGFR)",
      "validation": {
        "min": 15,
        "max": 150
      },
      "unit": "mL/min/1.73m²"
    },
    {
      "name": "risk_region",
      "type": "string",
      "required": true,
      "description": "Cardiovascular risk region based on country",
      "options": ["low", "moderate", "high", "very_high"]
    }
  ],
  "result": {
    "name": "cvd_risk",
    "type": "float",
    "unit": "%",
    "description": "10-year cardiovascular disease risk percentage"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 2.5,
        "stage": "Low to Moderate Risk",
        "description": "Low to moderate risk (<2.5% for age <50 years)",
        "interpretation": "Consider lifestyle interventions. Reinforce healthy lifestyle choices including diet, physical activity, and smoking cessation if applicable."
      },
      {
        "min": 2.5,
        "max": 5,
        "stage": "Moderate Risk",
        "description": "Moderate risk (2.5-5% for age <50 years or <5% for age 50-69 years)",
        "interpretation": "Lifestyle interventions recommended. Consider risk factor treatment if other risk factors present."
      },
      {
        "min": 5,
        "max": 7.5,
        "stage": "High Risk",
        "description": "High risk (5-7.5% for age <50 years or 5-10% for age 50-69 years)",
        "interpretation": "Consider risk factor treatment including lipid-lowering therapy and blood pressure management. Intensive lifestyle modification essential."
      },
      {
        "min": 7.5,
        "max": 10,
        "stage": "High Risk",
        "description": "High risk (7.5-10% for age 50-69 years)",
        "interpretation": "Recommend risk factor treatment including lipid-lowering therapy (statins) and blood pressure management. Intensive diabetes control and lifestyle modification."
      },
      {
        "min": 10,
        "max": 100,
        "stage": "Very High Risk",
        "description": "Very high risk (≥7.5% for age <50 years or ≥10% for age 50-69 years)",
        "interpretation": "Recommend intensive risk factor treatment including high-intensity statins, blood pressure management, and optimal diabetes control. Consider additional therapies such as SGLT2 inhibitors or GLP-1 receptor agonists with cardiovascular benefit."
      }
    ]
  },
  "references": [
    "SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023 Jul 21;44(28):2544-2556. doi: 10.1093/eurheartj/ehad260.",
    "Pennells L, Kaptoge S, Østergaard HB, Read SH, Carinci F, Franch-Nadal J, et al. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J. 2023 Jul 21;44(28):2544-2556.",
    "Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484."
  ],
  "formula": "Uses Fine and Gray competing risk models with diabetes-specific variables (HbA1c, age at diagnosis, eGFR) added to conventional SCORE2 risk factors, calibrated to four European risk regions",
  "notes": [
    "For patients with type 2 diabetes aged 40-69 years without previous cardiovascular disease",
    "Risk thresholds are age-specific: <50 years vs 50-69 years",
    "Countries are grouped into four risk regions based on WHO CVD mortality rates",
    "Consider diabetes-specific interventions (SGLT2i, GLP-1 RA) in addition to standard cardiovascular risk reduction",
    "For patients ≥70 years, consider using SCORE2-OP"
  ]
}